Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB26FWQMR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg tablets (120-count units) with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order was awarded on October 24, 2025, without a set-aside designation, allowing the vendor to compete in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its location in Park Ridge, IL 60068.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for comprehensive pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FWQMR?
SPE2DB26FWQMR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FWQMR worth?
The government has obligated $4,170 on SPE2DB26FWQMR.
Is contract SPE2DB26FWQMR an order under another contract?
Yes. SPE2DB26FWQMR is a delivery order under SPE2DB25D9307, an indefinite delivery contract.
Was contract SPE2DB26FWQMR competed?
The extent of competition for SPE2DB26FWQMR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award